Literature DB >> 15708202

Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment.

Elise J Levinoff1, Daniel Saumier, Howard Chertkow.   

Abstract

Reaction time (RT) tasks take various forms, and can assess psychomotor speed, (i.e., simple reaction time task), and focused attention (i.e., choice reaction time (CRT) task). If cues are provided before stimulus presentation (i.e., cued choice reaction time (CCRT) task), then a cueing effect can also be assessed. A limited number of studies have addressed the nature of focused attention impairments in Alzheimer's disease (AD). Additionally, it is unknown whether similar impairments occur in Mild Cognitive Impairment (MCI). The current study used three RT tasks to address the nature of focused attention impairments in AD and MCI subjects. The results suggest that there were significant CRT and CCRT differences in AD subjects when compared to NECs. Furthermore, slowed RTs were also present in the MCI group, which provides evidence for impaired focussed attention and the inability to benefit from a cue in both the MCI and AD groups. The implications of the impairments related to the MCI group could potentially prove useful in early diagnosis of cognitive impairments in the elderly.

Entities:  

Mesh:

Year:  2005        PMID: 15708202     DOI: 10.1016/j.bandc.2004.08.058

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  22 in total

1.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Distinctive features of microsaccades in Alzheimer's disease and in mild cognitive impairment.

Authors:  Zoi Kapoula; Qing Yang; Jorge Otero-Millan; Shifu Xiao; Stephen L Macknik; Alexandre Lang; Marc Verny; Susana Martinez-Conde
Journal:  Age (Dordr)       Date:  2013-09-15

4.  Model-based assessment and neural correlates of spatial memory deficits in mild cognitive impairment.

Authors:  Alexander S Weigard; K Sathian; Benjamin M Hampstead
Journal:  Neuropsychologia       Date:  2019-11-05       Impact factor: 3.139

5.  Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).

Authors:  Carola Romberg; Mark P Mattson; Mohamed R Mughal; Timothy J Bussey; Lisa M Saksida
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

6.  Dual task-related gait changes in patients with mild cognitive impairment.

Authors:  Alberto Nascimbeni; Shiva Caruso; Adriana Salatino; Marinella Carenza; Marta Rigano; Andrea Raviolo; Raffaella Ricci
Journal:  Funct Neurol       Date:  2015 Jan-Mar

7.  Corticothalamic network dysfunction and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Anupam Hazra; Brian F Corbett; Jason C You; Suzan Aschmies; Lijuan Zhao; Ke Li; Angelo C Lepore; Eric D Marsh; Jeannie Chin
Journal:  Neurobiol Aging       Date:  2016-04-29       Impact factor: 4.673

8.  Cognitive Correlates of Digital Clock Drawing Metrics in Older Adults with and without Mild Cognitive Impairment.

Authors:  Catherine Dion; Franchesca Arias; Shawna Amini; Randall Davis; Dana Penney; David J Libon; Catherine C Price
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health.

Authors:  Paul Bentley; Jon Driver; Ray J Dolan
Journal:  Brain       Date:  2007-12-12       Impact factor: 13.501

10.  Quantitative EEG Markers in Mild Cognitive Impairment: Degenerative versus Vascular Brain Impairment.

Authors:  D V Moretti; O Zanetti; G Binetti; G B Frisoni
Journal:  Int J Alzheimers Dis       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.